Ischemic brain tissue

Ischemic brain tissue refers to cerebral tissue that has been deprived of adequate blood supply, leading to a deficiency in oxygen and nutrients necessary for cellular metabolism. This condition is primarily associated with ischemic stroke, where a blockage in a blood vessel results in a core of irreversible damage (infarct) surrounded by a salvageable region known as the penumbra (StatPearls, 2023). At the cellular level, ischemia triggers a cascade of events including excitotoxicity, oxidative stress, and neuroinflammation, ultimately leading to neuronal death via apoptosis or necrosis (PubMed, PMID: 30241593). While not a single molecular target, ischemic brain tissue is the site of action for various neuroprotective and thrombolytic therapies. Drugs like Alteplase aim to restore blood flow, while experimental neuroprotective agents target specific pathways within this tissue to limit secondary damage (NIH, 2022). Understanding the temporal and spatial evolution of ischemic brain tissue is critical for developing interventions that extend the therapeutic window for stroke patients.

Other names

Ischemic brainInfarcted brain tissueCerebral ischemic tissueStroke-affected brain tissue

Not applicable as a single molecular target; therapeutic strategies involve thrombolysis to restore perfusion or neuroprotection to inhibit cell death pathways within the affected tissue.